Left Heart Abnormalities in Patients With Lung Disease, OSA, and Chronic Thromboemboli at Risk for or With Known Pulmonary Hypertension

Quantifying pretest probability for HFpEF in patients with sleep apnea, lung disease, or chronic thromboemboli identifies a progressive gradient for dynamic PCWP abnormalities with worse functional status and quality of life. These subclinical left heart abnormalities are not universally detectable by resting right heart catheterization alone and call for further study of whether strategies to prevent or treat HFpEF might improve functional status in these patients with high risk of occult HFpEF.

Authors

Institutions

Publication Details

Journal
Circulation Heart Failure
Published
2025-05-29
DOI
https://doi.org/10.1161/circheartfailure.125.012912
Citations
5
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
7.59
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Left Heart Abnormalities in Patients With Lung Disease, OSA, and Chronic Thromboemboli at Risk for or With Known Pulmonary Hypertension

J. Emanuel Finet, Paul M. Hassoun, Serpil C. Erzurum, Barry A. Borlaug et al.
5 citations
Circulation Heart Failure
Pulmonary Hypertension Research and Treatments
7.59
article

Left Heart Abnormalities in Patients With Lung Disease, OSA, and Chronic Thromboemboli at Risk for or With Known Pulmonary Hypertension

J. Emanuel Finet, Paul M. Hassoun, Serpil C. Erzurum, Barry A. Borlaug, Yogesh N.V. Reddy, Stephen C. Mathai, W.H. Wilson Tang, Christine Jellis, Evelyn M. Horn, Anna R. Hemnes, Jane A. Leopold, Franz Rischard, Nicholas S. Hill, Robert P. Frantz, Erika B. Rosenzweig, Reena Mehra, Gerald J. Beck
article en
5 citations

Abstract

Quantifying pretest probability for HFpEF in patients with sleep apnea, lung disease, or chronic thromboemboli identifies a progressive gradient for dynamic PCWP abnormalities with worse functional status and quality of life. These subclinical left heart abnormalities are not universally detectable by resting right heart catheterization alone and call for further study of whether strategies to prevent or treat HFpEF might improve functional status in these patients with high risk of occult HFpEF.

Circulation Heart FailureVol. 18(8)
Brigham and Women's Hospital (US), Tufts Medical Center (US), Cleveland Clinic (US), Mayo Clinic (US), Johns Hopkins University (US), University of Washington (US), Cornell University (US), Johns Hopkins Medicine (US), Cleveland Clinic Lerner College of Medicine (US), Maria Fareri Children's Hospital (US), Pulmonary and Allergy Associates (US), Mayo Clinic in Arizona (US), Mayo Clinic in Florida (US), Pulmonary and Critical Care Associates (US), Vanderbilt University Medical Center (US)
Good health and well-being
Openalex Percentile: Top 3%
Pulmonary Hypertension Research and Treatments
7.59
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.